Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2000
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054788A1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
09/21/2000WO2000054782A1 Treatment of accidental extravasation of anthracyclines
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054761A2 Regulation of phospholipase d activity
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000054758A2 Method for delivering benzidine prostaglandins by inhalation
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040583A3 Imidazo[4,5-c]-pyridine-4-on-derivatives
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000039154A3 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000032577A3 Substituted benzo[de]isoquinoline-1,3-diones
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000001668A3 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/21/2000DE19912573A1 Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D A drug containing doxazosin mesylate of Kristallmodifikaton D
09/21/2000DE19912063A1 Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation New process for the preparation of doxazosin mesylate in a crystal modification, referred to as Form A
09/21/2000CA2675416A1 Lipoxin compounds and their use
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000CA2367595A1 Lxr modulators
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364568A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361277A1 49 human secreted proteins
09/20/2000EP1036783A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/20/2000EP1036566A1 Preparation for continuous intravenous administration
09/20/2000EP1036510A2 Vitamin formulation for cardiovascular health
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036168A1 Purification and microsequencing of hyaluronidase isozymes
09/20/2000EP1036086A1 Caspase-14 polypeptides
09/20/2000EP1036078A1 Thienopyrimidines
09/20/2000EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
09/20/2000EP1036072A1 Thrombin receptor antagonists
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
09/20/2000EP1036063A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035859A1 THE USE OF PHOSPHOLIPID COMPLEXES OF EXTRACTS OF $i(VITIS VINIFERA) AS ANTI-ATHEROSCLEROTIC AGENTS
09/20/2000EP1035856A1 Isolated dna encoding human h3 histamine receptor
09/20/2000EP1035851A2 Method for combating obesity
09/20/2000EP1035845A1 Modulators of cysteine protease
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP0766735B1 Class bi and ci scavenger receptors
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000EP0705816B1 Benzene derivative useful for ischemic diseases
09/20/2000CN1267331A Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
09/20/2000CN1267306A Cyclopeptide derivs. as adhesion inhibitors
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
09/20/2000CN1267217A Solid pharmaceutical composition contg. benzofurane derivs.
09/20/2000CN1266688A 活性双歧杆菌胶囊 Active Bifidobacterium Capsules
09/20/2000CN1266682A Quick-acting aerosol for treating stenocardia and preparing process thereof
09/20/2000CN1056610C Piperidine or piperazine derivs, pharmaceutical compositions contg. them and their use
09/20/2000CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056607C Tricyclic pyrazole derivs.
09/20/2000CN1056606C Substd. dihydro-pyridine dicarboxylate, its preparing method, medicine contg. same and use thereof
09/20/2000CN1056605C Compounds as selective human NK 3-receptor antagonists and their use
09/20/2000CN1056602C Esters and amides as PLAZ inhibitors
09/20/2000CN1056535C Medicine for curing atherosclerosis
09/20/2000CN1056532C Blood pressure depressing Yongquan plaster
09/19/2000US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121375 Gels formed by the interaction of poly(aldehyde) with various substances
09/19/2000US6121330 Cardiovascular disorders; anticholesterol agents; antilipemic agents
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals
09/19/2000US6121304 Pentafluorobenzenesulfonamides and analogs
09/19/2000US6121300 In a topical cosmetic as skin elasticity improver or wrinkle reducer; compounds such as 3-(2-(3-phenyl-5-isoxazolyl)-2-oxoethyl)-thiazolium; adminsistering to treat cataracts, protein aging and diabetes
09/19/2000US6121280 Azabicyclic rotomase inhibitors
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121265 Excitatory amino acid receptor antagonists
09/19/2000US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist
1 ... 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 ... 1595